STAT1 and cancer: Additionally, a correlation of STAT1 expression in cancer patients tends to have a better clinical prognosis, including colon-rectal cancer, soft tissue sarcoma, metastatic melanoma, hepatocellular carcinoma, and pancreatic cancer [94–97].